Decision based on data involving use of SpaceOAR® hydrogel to protect surrounding tissue during radiotherapy to treat prostate cancer. BEDFORD, Mass.--(BUSINESS WIRE)--Augmenix, Inc., a medical ...
DALLAS, March 14, 2018 /PRNewswire-PRWeb/ -- Urology Clinics of North Texas is pleased to announce the arrival of a new system for men choosing to undergo radiation therapy for prostate cancer. The ...
BEDFORD, Mass.--(BUSINESS WIRE)-- Augmenix, Inc. is pleased to announce that the company’s leading product, SpaceOAR hydrogel, is now available to millions of American men covered under Medicare, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback